On estimation of optimal treatment regimes for maximizing t-year survival probability

被引:42
作者
Jiang, Runchao [1 ]
Lu, Wenbin [1 ]
Song, Rui [1 ]
Davidian, Marie [1 ]
机构
[1] North Carolina State Univ, Raleigh, NC USA
基金
美国国家卫生研究院;
关键词
Inverse probability weighted estimation; Kaplan-Meier estimator; Optimal treatment regime; Personalized medicine; Survival probability; Value function; ESTIMATING INDIVIDUALIZED TREATMENT; MODELS; REGRESSION; DESIGN;
D O I
10.1111/rssb.12201
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
A treatment regime is a deterministic function that dictates personalized treatment based on patients' individual prognostic information. There is increasing interest in finding optimal treatment regimes, which determine treatment at one or more treatment decision points to maximize expected long-term clinical outcomes, where larger outcomes are preferred. For chronic diseases such as cancer or human immunodeficiency virus infection, survival time is often the outcome of interest, and the goal is to select treatment to maximize survival probability. We propose two non-parametric estimators for the survival function of patients following a given treatment regime involving one or more decisions, i.e. the so-called value. On the basis of data from a clinical or observational study, we estimate an optimal regime by maximizing these estimators for the value over a prespecified class of regimes. Because the value function is very jagged, we introduce kernel smoothing within the estimator to improve performance. Asymptotic properties of the proposed estimators of value functions are established under suitable regularity conditions, and simulation studies evaluate the finite sample performance of the regime estimators. The methods are illustrated by application to data from an acquired immune deficiency syndrome clinical trial.
引用
收藏
页码:1165 / 1185
页数:21
相关论文
共 21 条
[1]  
Bai X., 2014, TECHNICAL REPORT
[2]  
Cheng SC, 1995, BIOMETRIKA, V82, P835, DOI 10.1093/biomet/82.4.835
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   Q-LEARNING WITH CENSORED DATA [J].
Goldberg, Yair ;
Kosorok, Michael R. .
ANNALS OF STATISTICS, 2012, 40 (01) :529-560
[5]   A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter [J].
Hammer, SM ;
Katzenstein, DA ;
Hughes, MD ;
Gundacker, H ;
Schooley, RT ;
Haubrich, RH ;
Henry, WK ;
Lederman, MM ;
Phair, JP ;
Niu, M ;
Hirsch, MS ;
Merigan, TC ;
Blaschke, TF ;
Simpson, D ;
McLaren, C ;
Rooney, J ;
Salgo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1081-1090
[6]   Smoothed rank regression with censored data [J].
Heller, Glenn .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2007, 102 (478) :552-559
[7]   Evaluating Marker-Guided Treatment Selection Strategies [J].
Matsouaka, Roland A. ;
Li, Junlong ;
Cai, Tianxi .
BIOMETRICS, 2014, 70 (03) :489-499
[8]  
Mebane WR, 2011, J STAT SOFTW, V42, P1
[9]   An experimental design for the development of adaptive treatment strategies [J].
Murphy, SA .
STATISTICS IN MEDICINE, 2005, 24 (10) :1455-1481
[10]   Optimal dynamic treatment regimes [J].
Murphy, SA .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2003, 65 :331-355